OnKure Therapeutics, Inc. (OKUR) Live Share Price, Invest From India

OnKure Therapeutics, Inc. Stock Performance

as on May 13, 2026 at 6:59 am IST

Day's Low
Day's High
$3.38
Day's Price Range
$3.54
$3.42
1.17%
Downside
3.51%
Upside
52 Week's Low
52 Week's High
$1.70
52-Week Price Range
$5.38
$3.42
50.29%
Downside
57.31%
Upside

OnKure Therapeutics, Inc. share price movements today

Previous Close: $3.44
Open: $3.42
Volume: 289.8K
Day's Low - High: $3.38 - $3.54
52 Week Low - High: $1.70 - $5.38

OnKure Therapeutics, Inc. Historical Returns

1 Month Return: -20 %
3 Month Return: + 42.74 %
1 Year Return: + 76.41 %
3 Year Return: 0 %
5 Year Return: 0 %

OnKure Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check OnKure Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$157.9M

EPS (TTM)

-2.795

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-42.73%

OnKure Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of OnKure Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
OnKure Therapeutics, Inc.	NA	$157.9M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.4B	113.59%	74.13	12.55%
BeiGene, Ltd.	NA	$32.2B	NA	70.46	8.94%
Vertex Pharmaceuticals Inc	BUY	$109.1B	104.61%	25.51	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.9B	40.55%	17.45	29.65%

Stock Returns calculator for OnKure Therapeutics, Inc. Stock including INR - Dollar returns

The OnKure Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

OnKure Therapeutics, Inc. investment value today

Current value as on today

₹1,97,562

Returns

₹97,562

(+97.56%)

Returns from OnKure Therapeutics, Inc. Stock

₹75,385 (+75.38%)

Dollar Impact

₹22,177 (+22.18%)

Indian Investors' Interest in OnKure Therapeutics, Inc. Stock

Search interest for OnKure Therapeutics, Inc. Stock has increased by 54% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:54% versus previous 30 day period

OnKure Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	-	0
Operating Income	21	-9	-14	-4	-33	-17	-16	-15	-14
EBITDA	21	-9	-13	-3	-31	-16	-15	-14	-13
Interest Expense	-	-	0	0	-	-	-	0	0
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	18	-9	-14	-3	-35	-15	-15	-14	-13
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	18	-9	-14	-3	-35	-15	-15	-14	-13
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

OnKure Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-
Gross Profit	0	0	0	0
Operating Income	-29	-36	-54	-62
EBITDA	-29	-34	-51	-62
Interest Expense	-	-	0	0
Depreciation	0	0	0	0
Income Before Tax	-29	-35	-52	-59
Income Tax Expense	-	-	-	-
Net Income	-29	-35	-52	-59
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

OnKure Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-9	-14	-11	-35	-15	-15	-14	-13	-15
Operating Cash Flow	-10	-6	-10	-21	-14	-13	-13	-11	-12
Investing Cash Flow	0	0	0	-45	0	0	0	0	0
Financing Cash Flow	0	5	0	114	0	-	-	0	145
Change in Cash	-10	0	-10	50	-14	-13	-13	-11	133

OnKure Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-39	-29	-35	-52	-59
Operating Cash Flow	-37	-26	-34	-51	-51
Investing Cash Flow	-23	-1	0	15	0
Financing Cash Flow	132	26	53	116	0
Change in Cash	71	-1	18	80	-51

Insights on OnKure Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, OKUR has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 30.4% return, outperforming this stock by 126.2%
NEGATIVE IMPACT
Price Dip
In the last 7 days, OKUR stock has moved down by -15.5%

About OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.

Organisation	OnKure Therapeutics, Inc.
Headquarters	6707 Winchester Circle, Boulder, CO, United States, 80301
Industry	Biotechnology
CEO	Dr. Nicholas A. Saccomano Ph.D.
E-voting on shares	Click here to vote

Key Management of OnKure Therapeutics, Inc.

Name	Title
Mr. Jason A. Leverone CPA	Chief Financial Officer
Dr. James Blake Ph.D.	Senior Vice President of Computational Drug Discovery
Dr. Kevin S. Litwiler Ph.D.	Senior Vice President of DMPK & Clinical Pharmacology
Dr. Nicholas A. Saccomano Ph.D.	President, CEO & Director
Dr. Samuel Agresta M.D., M.P.H.	Chief Medical Officer
Dr. Dylan Hartley Ph.D.	Chief Scientific Officer
Mr. Rogan P. Nunn J.D.	General Counsel & Secretary
Dr. Mark L. Boys Ph.D.	Senior Vice President of Discovery Chemistry
Ms. Roberta Alton	Senior Vice President of Clinical Operations
Dr. Isaac Manke Ph.D.	Senior VP of Business Development & Director

FAQs

What is OnKure Therapeutics, Inc. share price today?

OnKure Therapeutics, Inc. share price today is $3.42 as on May 13, 2026 at 1:29 am IST at the close of the market. OnKure Therapeutics, Inc. share today touched a day high of $3.54 and a low of $3.38.

What is the 52 week high and 52 week low for OnKure Therapeutics, Inc. share?

OnKure Therapeutics, Inc. share touched a 52 week high of $5.38 on May 1, 2026 and a 52 week low of $1.7 on May 13, 2025. OnKure Therapeutics, Inc. stock price today i.e. May 13, 2026 at 1:29 am IST is closed at $3.42,which is 36.43% down from its 52 week high and 101.18% up from its 52 week low.

What is OnKure Therapeutics, Inc.'s market capitalisation today?

OnKure Therapeutics, Inc. market capitalisation is $0.00T as on May 13, 2026 at 1:29 am IST.

How to invest in OnKure Therapeutics, Inc. Stock (OKUR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for OnKure Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in OnKure Therapeutics, Inc. Shares that will get you 0.4386 shares as per OnKure Therapeutics, Inc. share price of $3.42 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy OnKure Therapeutics, Inc. Stock (OKUR) from India?

Indian investors can start investing in OnKure Therapeutics, Inc. (OKUR) shares with as little as ₹95.618 or $1 (as of May 13, 2026 at 6:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in OnKure Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 6:39 am IST). Based on OnKure Therapeutics, Inc. share’s latest price of $3.42 as on May 13, 2026 at 1:29 am IST, you will get 2.9240 shares of OnKure Therapeutics, Inc.. Learn more about fractional shares .